Why the study?
Does gallic acid prevent doxorubicin-induced myocardial toxicity in albino rats?
Population
Adult Wistar albino rats of either sex weighing 150-200 g with doxorubicin-induced cardiotoxicity
Comparison
Gallic acid vs Control (doxorubicin alone)
Design
Preclinical
Follow-up
2 weeks
Authors
Loading...
Gallic acid effects remain preclinical in rats; hypothesis-generating and should not yet inform doxorubicin cardioprotection in patients.
Does gallic acid prevent doxorubicin-induced myocardial toxicity in albino rats?
Gallic acid demonstrates cardioprotective effects against doxorubicin-induced myocardial toxicity in a rat model, likely mediated through its antioxidant properties.
Swamy et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: